AI assistant
Sending…
Iterum Therapeutics plc — Director's Dealing 2019
Jun 17, 2019
34796_dirs_2019-06-17_2bceb846-c699-4723-909c-ecb465b35589.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2019-06-13
Reporting Person: Ahrens Brenton Karl (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-13 | Stock Option (Right to Buy) | $6.74 | A | 19671 | Acquired | 2029-06-12 | Ordinary Shares (19671) | Direct |
Footnotes
F1: Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Equity Incentive Plan, the shares subject to this option shall vest on June 13, 2020.
More from Iterum Therapeutics plc
Delisting Announcement
2026
Mar 31
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 3
Delisting Announcement
2026
Mar 2
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 18
Proxy Solicitation & Information Statement
2026
Jan 2
Proxy Solicitation & Information Statement
2025
Dec 23
Delisting Announcement
2025
Dec 12
Director's Dealing
2025
Nov 20
Interim / Quarterly Report
2025
Nov 14